Literature DB >> 619945

Contribution of individual differences in gastric emptying to variability in plasma propranolol concentrations.

C M Castleden, C F George, M D Short.   

Abstract

1 No correlation was found between the rate of gastric emptying and peak plasma propranolol concentrations in six hypertensive patients after single oral doses of 80 mg. 2 In four normal subjects given oral propranolol the peak plasma concentration was highest when a simultaneous injection of metoclopramide and lowest when propantheline was given. The mean time to peak was 1.5 h after metoclopramide, 2.8 h after normal saline and 4.5 h after propantheline. 3 Gastric emptying has some influence on the time of peak plasma propranolol concentrations but individual variation in its bioavailability is determined mainly by first-pass metabolism in the liver.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 619945      PMCID: PMC1429240          DOI: 10.1111/j.1365-2125.1978.tb01610.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Contribution of the liver to overall elimination of propranolol.

Authors:  C F George; M L Orme; P Buranapong; D Macerlean; A M Breckenridge; C T Dollery
Journal:  J Pharmacokinet Biopharm       Date:  1976-02

2.  Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

Authors:  G H Evans; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

3.  The disposition of propranolol. I. Elimination during oral absorption in man.

Authors:  D G Shand; R E Rangno
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

4.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

5.  Measurement of gastric emptying using the scintillation camera and 129Cs.

Authors:  T Jones; J C Clark; N Kocak; A G Cox; H I Glass
Journal:  Br J Radiol       Date:  1970-08       Impact factor: 3.039

6.  Propranolol dose determinants including blood level studies.

Authors:  C E McLean; B C Deane
Journal:  Angiology       Date:  1970-09       Impact factor: 3.619

  6 in total
  8 in total

1.  Absorption of propranolol in humans following oral, jejunal, and ileal administration.

Authors:  A Buch; W H Barr
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

2.  Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerations.

Authors:  P Mojaverian; P H Vlasses; P E Kellner; M L Rocci
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

Review 3.  Drug kinetics and hepatic blood flow.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

4.  Gastrointestinal transit of a solid indigestible capsule as measured by radiotelemetry and dual gamma scintigraphy.

Authors:  P Mojaverian; K Chan; A Desai; V John
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

5.  Gastric emptying of enteric-coated tablets.

Authors:  H M Park; S M Chernish; B D Rosenek; R L Brunelle; B Hargrove; H N Wellman
Journal:  Dig Dis Sci       Date:  1984-03       Impact factor: 3.199

6.  Influence of cimetidine on pharmacokinetics of propranolol.

Authors:  A M Heagerty; M A Donovan; C M Castleden; J F Pohl; L Patel; A Hedges
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

7.  Cimetidine increases steady state plasma levels of propranolol.

Authors:  I W Reimann; U Klotz; B Siems; J Frölich
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

8.  Plasma propranolol concentrations and the erythrocyte sedimentation rate.

Authors:  R E Schneider; H Bishop; C F Hawkins
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.